At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
Pancreatic cancer is a very poor prognosis. It is caused in more than 80% of cases by oncogenic mutations of the protein called Kras. This mutated Kras protein is active by direct interaction of PI3K proteins. Until now, the subtype of Kras mutation was considered...
The fact that many people suffer from more than one disease, known as comorbidity, has become one of the main challenges for the 21st century aging population, as it mainly affects the elderly, decreasing treatment options and patients’ life expectancy while...
Despite considerable research efforts, cancers remain the second leading cause of death in developed countries. Why so many more therapeutic failures? The reasons are multiple, the tumors are not always accessible to surgery, the current chemotherapy remains very...
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE